Diatech
Founded 1970 · 788 employees on LinkedIn · 1 known investors
Diatech Diabetes is a medical device company developing SmartFusion, a software platform and mobile app that monitors insulin infusion pumps for medication delivery failure and measures the accuracy of insulin delivery for people living with diabetes. The technology is in development and its core assets and IP have been acquired by DEKA Research & Development.
Founders & leadership
Diatech was founded in 1970 by John Wilcox and Luis E. Blanco.
JW
John WilcoxCo-founder & CEO
LE
Luis E. BlancoCo-founder & CTO
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Diatech do?
- Diatech Diabetes is a medical device company developing SmartFusion, a software platform and mobile app that monitors insulin infusion pumps for medication delivery failure and measures the accuracy of insulin delivery for people living with diabetes. The technology is in development and its core assets and IP have been acquired by DEKA Research & Development.
- Who founded Diatech?
- Diatech was founded by John Wilcox, Luis E. Blanco in 1970.
- Who are Diatech's investors?
- Diatech's investors include Launch Tennessee.